INKT
MiNK Therapeutics, Inc.
Company overview
- Market capitalization
- $61.80M
- Employees
- 15
- Latest publication
- 2026-09-29
About MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company develops agenT-797, an off-the-shelf, allogeneic, and native iNKT cell therapy that is in Phase 2 clinical trial for the clinical safety and efficacy of the combination of agenT-797, botensilimab and balstilimab with ramucirumab and paclitaxel for patients with previously treated, advanced esophageal, gastric, or gastroesophageal junction adenocarcinoma; Phase 1 trial as a monotherapy in combination with anti-PD-1 checkpoint inhibitors, pembrolizumab, and nivolumab for refractory solid tumor cancers; and Phase 1 trial for the treatment of moderate to severe viral acute respiratory distress syndrome (ARDS). It is also developing MiNK-215, an IL-15 armored tumor stromal targeting the FAP-CAR-iNKT program to treat solid tumors and inflammation; and MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen for autoimmune diseases, including in graft-versus-host disease prevention. The company has collaborations with Autonomous Therapeutics to target and treat metastatic tumors; ImmunoScape, Inc. to discover and develop T-cell receptor therapies against targets in solid tumors; and C-Further for the development of PRAME-targeted iNKT cell therapy for pediatric cancers. The company was formerly known as AgenTus Therapeutics, Inc. and changed its name to MiNK Therapeutics, Inc. in June 2021. The company was incorporated in 2017 and is based in New York, New York.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 3,769,421,862USD | 0USD | 0USD |
| Cost Of Revenue | 36,066USD | 38,563USD | 43,654USD | 48,763USD | 50,765USD | 53,869USD | 62,637USD | 45,100USD |
| Gross Profit | -36,066USD | -38,563USD | -43,654USD | -48,763USD | -50,765USD | -53,869USD | -62,637USD | -45,100USD |
| Research Development | 1,204,090,000USD | 5,753,242,744USD | 1,143,178USD | 1,839,176USD | 1,261,902USD | 1,406,000USD | 540,638USD | 1,839,874USD |
| Selling General Administrative | 1,677,697,000USD | 6,727,967,870USD | 1,846,495,000USD | 1,849,130USD | 1,270,863,000USD | 808,904USD | 1,163,033USD | 1,061,793USD |
| Unclassified Operating Expenses | -2,878,941,279USD | -12,477,972,618USD | -1,844,692,159USD | — | -1,269,642,902USD | — | — | — |
| Total Operating Expenses | 2,845,721USD | 3,237,996USD | 2,946,019USD | 3,639,543USD | 2,482,000USD | 2,161,131USD | 1,641,034USD | 2,856,567USD |
| Operating Income | -2,881,787USD | -3,276,559USD | -2,989,673USD | -3,688,306USD | -2,532,765USD | -2,215,000USD | -1,703,671USD | -2,901,667USD |
| Interest Income | 80,834USD | 111,230USD | 55,151USD | 348USD | 13,517USD | 39,573USD | 78,015USD | 38,360USD |
| Net Interest Income | 80,834USD | 111,230USD | 55,151USD | 348USD | 13,517USD | 39,573USD | 78,015USD | 38,360USD |
| Income Before Tax | -2,742,368USD | -2,602,103USD | -2,887,709USD | -4,237,751USD | -2,766,697USD | -2,464,000USD | -1,806,597USD | -2,701,806USD |
| Net Income | -2,742,368USD | -2,602,103USD | -2,887,709USD | -4,237,751USD | -2,766,697USD | -2,464,000USD | -1,806,597USD | -2,701,806USD |
| Net Income From Continuing Ops | -2,742,368USD | -2,602,103USD | -2,887,709USD | -4,237,751USD | -2,766,697USD | -2,463,104USD | -1,806,597USD | -2,701,806USD |
| Ebit | -2,881,787USD | -2,595,143USD | -2,887,713USD | -4,237,748USD | -2,766,700USD | -2,463,998USD | -1,806,597USD | -2,701,801USD |
| Ebitda | -2,845,721USD | -2,556,580USD | -2,844,059USD | -4,188,985USD | -2,715,935USD | -2,410,129USD | -1,743,960USD | -2,656,701USD |
| Depreciation And Amortization | 36,066USD | 38,563USD | 43,654USD | 48,763USD | 50,765USD | 53,869USD | 62,637USD | 45,100USD |
| Reconciled Depreciation | 36,066USD | 38,563USD | 43,654USD | 48,763USD | 50,765USD | 53,869USD | 62,637USD | 45,100USD |
| Total Other Income Expense Net | 139,419USD | 674,456USD | 101,964USD | -549,445USD | -233,932USD | -249,000USD | -102,926USD | 199,861USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 2,704,743,000USD | 0USD | 0USD | 689,626USD |
| Cost Of Revenue | 181,745USD | 215,437USD | 204,617USD | 121,749USD | 77,960USD | 55,060USD | — |
| Gross Profit | -181,745USD | -215,437USD | -204,617USD | -121,749USD | -77,960USD | -55,060USD | 689,626USD |
| Research Development | 5,757,487,000USD | 6,336,075USD | 15,489,997USD | 23,115,123USD | 13,966,368USD | 9,509,055USD | 19,654,135USD |
| Selling General Administrative | 6,729,817,000USD | 4,314,164,000USD | 7,431,108USD | 7,834,155USD | 4,639,928USD | 1,287,656USD | 3,828,040USD |
| Unclassified Operating Expenses | -12,474,998,441USD | -4,310,065,273USD | — | — | — | — | — |
| Total Operating Expenses | 12,305,559USD | 10,434,802USD | 22,716,488USD | 30,827,529USD | 18,528,336USD | 10,741,651USD | 22,974,104USD |
| Operating Income | -12,487,304USD | -10,650,239USD | -22,921,105USD | -30,949,278USD | -18,606,296USD | -10,796,711USD | -22,284,478USD |
| Interest Income | 180,246USD | 172,568USD | 463,256USD | 253,323USD | — | — | — |
| Net Interest Income | 180,246USD | 172,568USD | 556,566USD | 253,323USD | -2,431,614USD | -2,440,903USD | -1,560,868USD |
| Income Before Tax | -12,494,260USD | -10,784,802USD | -22,457,859USD | -27,991,212USD | -30,212,770USD | -16,238,897USD | -23,802,182USD |
| Net Income | -12,494,260USD | -10,784,802USD | -22,457,859USD | -27,991,212USD | -30,212,770USD | -16,238,897USD | -23,802,182USD |
| Net Income From Continuing Ops | -12,494,260USD | -10,784,802USD | -24,769,001USD | -27,991,212USD | -30,212,770USD | -16,238,898USD | -23,802,182USD |
| Ebit | -12,487,304USD | -10,784,806USD | -22,457,859USD | -27,991,215USD | -27,781,156USD | -13,797,996USD | -22,241,314USD |
| Ebitda | -12,305,559USD | -10,569,369USD | -22,253,242USD | -27,869,466USD | -27,703,196USD | -13,742,936USD | -22,204,498USD |
| Depreciation And Amortization | 181,745USD | 215,437USD | 204,617USD | 121,749USD | 77,960USD | 55,060USD | 36,816USD |
| Reconciled Depreciation | 181,745USD | 215,437USD | 188,978USD | 121,749USD | 77,960USD | 55,060USD | 36,816USD |
| Total Other Income Expense Net | -6,956USD | -134,563USD | 463,246USD | 2,958,066USD | -11,606,474USD | -5,442,186USD | -1,517,704USD |
| Income Tax Expense | — | -10,774,017,198USD | 3USD | -3,211,389USD | -7,098,761USD | -560,381USD | 2,112,103USD |
| Interest Expense | — | — | — | 253,323USD | 2,431,614USD | 2,440,903USD | 1,560,868USD |
| Non Operating Income Net Other | — | — | — | 2,704,743USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -27,991,212USD | -30,212,770USD | -16,238,898USD | -23,802,182USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,615,242USD | 10,376,972USD | 14,963,665USD | 2,484,417USD | 4,267,313USD | 5,720,813USD | 7,374,742USD | 10,323,598USD |
| Cash And Equivalents | 8,806,977USD | — | — | — | — | — | — | — |
| Total Current Assets | 9,296,768USD | 10,022,454USD | 14,534,321USD | 2,011,202USD | 3,579,813USD | 4,987,884USD | 6,575,220USD | 9,473,641USD |
| Other Current Assets | 212,218USD | 496,778USD | 253,109USD | 329,287USD | 344,914USD | 410,844USD | 246,981USD | 159,973USD |
| Total Liabilities | 23,643,538USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 7,568,743USD | 7,287,425USD | 13,433,554USD | 13,163,565USD | 12,120,067USD | 6,959,676USD | 7,398,993USD | 10,147,359USD |
| Other Current Liabilities | 2,454,258USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -14,028,296USD | -12,685,989USD | -13,512,982USD | -25,189,315USD | -21,791,779USD | -19,585,882USD | -17,554,089USD | -16,576,142USD |
| Total Equity Including Noncontrolling Interest | -14,028,296USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 318,474USD | 354,518USD | 429,344USD | 473,215USD | 687,500USD | 732,929USD | 799,522USD | 849,957USD |
| Accounts Payable | 3,918,739USD | 3,391,418USD | 3,693,115USD | 3,314,839USD | 2,661,195USD | 2,728,212USD | 2,361,175USD | 3,202,146USD |
| Common Stock | 52USD | 51USD | 46USD | 40USD | 40USD | 40USD | 395USD | 394USD |
| Retained Earnings | -162,546,564USD | -159,418,363USD | -154,073,000USD | -151,186,183USD | -146,948,432USD | -144,181,735USD | -141,718,631USD | -139,912,034USD |
| Accumulated Other Comprehensive Income | -699,892USD | -697,426USD | -692,114USD | -719,318USD | -662,441USD | -631,576USD | -672,838USD | -611,375USD |
| Total Liab | — | 23,062,961USD | 28,476,647USD | 27,673,732USD | 26,059,092USD | 25,306,695USD | 24,928,831USD | 26,899,741USD |
| Other Current Liab | — | 3,896,007USD | 4,015,172USD | 4,342,380USD | 4,341,338USD | 4,231,464USD | 5,037,818USD | 6,945,213USD |
| Capital Stock | — | 51USD | 46USD | 40USD | 40USD | 40USD | 395USD | 394USD |
| Cash | — | 9,525,676USD | 14,281,212USD | 1,681,915USD | 3,234,899USD | 4,577,040USD | 6,328,239USD | 9,313,668USD |
| Cash And Short Term Investments | — | 9,525,676USD | 14,281,212USD | 1,681,915USD | 3,234,899USD | 4,577,040USD | 6,328,239USD | 9,313,668USD |
| Net Debt | — | -9,525,676USD | -8,555,945USD | 3,824,431USD | 1,882,635USD | 347,572USD | -1,716,595USD | -4,907,965USD |
| Property Plant Equipment Gross | — | 1,002,319USD | 1,002,947USD | 1,003,797USD | 1,266,044USD | 1,257,568USD | 1,276,263USD | 1,258,908USD |
| Common Stock Shares Outstanding | — | 4,798,000shares | 4,443,000shares | 3,981,992shares | 3,964,982shares | 3,773,326shares | 3,953,370shares | 3,714,202shares |
| Non Current Assets Total | — | 354,518USD | 429,344USD | 473,215USD | 687,500USD | 732,929USD | 799,522USD | 849,957USD |
| Non Current Liabilities Total | — | 15,775,536USD | 15,043,093USD | 14,510,167USD | 13,939,025USD | 18,347,019USD | 17,529,838USD | 16,752,381USD |
| Non Currrent Assets Other | — | 354,518,000USD | 0USD | — | 687,500,000USD | — | 799,522,000USD | -1USD |
| Net Working Capital | — | 2,735,029USD | 1,100,767USD | -11,152,363USD | -8,540,254USD | -1,971,792USD | -823,773USD | -673,718USD |
| Unclassified Non Current Assets | — | -354,518,000USD | — | — | -687,500,000USD | — | -799,522,000USD | — |
| Unclassified Non Current Liabilities | — | 15,775,536USD | 15,043,093USD | 14,510,167USD | 13,939,025USD | 13,422,407USD | 12,915,252USD | 12,323,398USD |
| Unclassified Equity | — | 147,429,698USD | 141,252,040USD | 126,716,106USD | 125,819,014USD | 125,227,349USD | 124,836,590USD | 123,946,479USD |
| Short Term Debt | — | — | 5,725,267USD | 5,506,346USD | 5,117,534USD | — | — | — |
| Short Long Term Debt | — | — | 5,725,267USD | 5,506,346USD | 5,117,534USD | — | — | — |
| Short Long Term Debt Total | — | — | 5,725,267USD | 5,506,346USD | 5,117,534USD | 4,924,612USD | 4,611,644USD | 4,405,703USD |
| Unclassified Current Liabilities | — | — | -5,725,267USD | -5,506,346USD | -5,117,534USD | — | — | — |
| Long Term Debt | — | — | — | — | — | 4,924,612USD | 4,611,644USD | 4,405,703USD |
| Other Assets | — | — | — | — | — | — | -6,568,644,780USD | 1USD |
| Short Term Investments | — | — | — | — | — | — | 6,321,910,761USD | — |
| Non Current Liabilities Other | — | — | — | — | — | — | 2,942USD | 23,280USD |
| Unclassified Current Assets | — | — | — | — | — | — | -6,321,910,761USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 5,720,813USD | 4,552,281USD | 21,471,602USD | 40,241,505USD | 4,555,178USD | 1,308,919USD |
| Other Current Assets | 410,844USD | 231,075USD | 768,967USD | 723,082USD | 612,638USD | 5,664USD |
| Total Liab | 25,306,695USD | 22,607,730USD | 21,872,905USD | 16,465,036USD | 58,429,354USD | 37,642,679USD |
| Total Stockholder Equity | -19,585,882USD | -18,055,449USD | -401,303USD | 23,776,469USD | -53,874,176USD | -36,333,760USD |
| Other Current Liab | 4,231,464USD | 7,490,612USD | 6,860,166USD | 13,469,391USD | 11,080,452USD | 4,771,703USD |
| Common Stock | 40USD | 346USD | 339USD | 335USD | 87USD | 241USD |
| Capital Stock | 40USD | 346USD | 339USD | 335USD | 242USD | 241USD |
| Retained Earnings | -144,181,735USD | -133,396,933USD | -110,939,074USD | -82,947,862USD | -52,735,092USD | -36,496,194USD |
| Other Assets | -732,196,071USD | 1USD | — | — | — | — |
| Cash | 4,577,040USD | 3,367,229USD | 19,635,725USD | 38,888,828USD | 2,691,156USD | 299,036USD |
| Cash And Short Term Investments | 4,577,040USD | 3,367,229USD | 19,635,725USD | 38,888,828USD | 2,691,156USD | 299,036USD |
| Total Current Assets | 4,987,884USD | 3,598,304USD | 20,404,692USD | 39,634,910USD | 3,557,794USD | 918,400USD |
| Total Current Liabilities | 6,959,676USD | 11,402,585USD | 12,683,166USD | 16,465,036USD | 14,222,296USD | 7,418,901USD |
| Net Debt | 347,572USD | -3,367,229USD | -19,635,725USD | -38,888,828USD | 41,132,844USD | 26,491,366USD |
| Short Long Term Debt Total | 4,924,612USD | — | — | — | 43,824,000USD | 26,790,402USD |
| Long Term Debt | 4,924,612USD | — | — | — | 43,824,000USD | 26,790,402USD |
| Short Term Investments | 4,572,462,960USD | — | — | — | — | — |
| Accounts Payable | 2,728,212USD | 3,911,973USD | 5,823,000USD | 2,995,645USD | 3,141,844USD | 2,456,186USD |
| Property Plant Equipment Net | 732,929USD | 953,977USD | 1,066,910USD | 606,595USD | 458,384USD | 390,519USD |
| Property Plant Equipment Gross | 1,257,568USD | 1,449,615USD | 1,350,592USD | 775,200USD | 556,544USD | 427,335USD |
| Accumulated Other Comprehensive Income | -631,576USD | -430,947USD | -292,468USD | -625,269USD | -1,523,038USD | -132,590USD |
| Common Stock Shares Outstanding | 3,863,348shares | 3,435,994shares | 3,367,292shares | 3,347,652shares | 3,308,730shares | 2,407,786shares |
| Non Current Assets Total | 732,929USD | 953,977USD | 1,066,910USD | 606,595USD | 997,383USD | 390,519USD |
| Non Current Liabilities Total | 18,347,019USD | 11,205,145USD | 9,189,739USD | 2,995,645USD | 44,207,058USD | 30,223,778USD |
| Non Currrent Assets Other | 732,929,000USD | -1USD | 0USD | 0USD | 538,999USD | 0USD |
| Net Working Capital | -1,971,792USD | -7,804,281USD | 7,721,526USD | 23,169,874USD | -10,125,502USD | -6,500,501USD |
| Unclassified Current Assets | -4,572,462,960USD | — | — | — | -1,031,060USD | — |
| Unclassified Non Current Assets | -732,929,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 13,422,407USD | 11,157,073USD | — | 2,995,645USD | — | -3,433,376USD |
| Unclassified Equity | 125,227,349USD | 115,771,739USD | 110,829,561USD | 107,348,930USD | — | — |
| Non Current Liabilities Other | — | 48,072USD | 9,189,739USD | — | 383,058USD | 3,433,376USD |
| Net Tangible Assets | — | — | -401,303USD | 23,776,469USD | -53,874,176USD | -36,333,760USD |
| Net Receivables | — | — | — | 23,000USD | 254,000USD | 526,000USD |
| Inventory | — | — | — | 1,761USD | 1,031,060USD | 87,700USD |
| Other Liab | — | — | — | — | 383,058USD | 3,433,376USD |
| Current Deferred Revenue | — | — | — | — | — | 191,012USD |
| Short Term Debt | — | — | — | — | — | 4,758,160USD |
| Unclassified Current Liabilities | — | — | — | — | — | -4,758,160USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 72,130USD |
| Stock Based Compensation | 1,052,588USD |
| Change To Liabilities | 494,301USD |
| Change In Working Capital | 494,301USD |
| Operating Cash Flow | -3,815,409USD |
| Financing Cash Flow | -734,676USD |
| Effect Of Forex Changes On Cash | -3,278USD |
| Change In Cash | -4,553,363USD |
| End Cash Flow | 8,806,977USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,742,368,000USD | -12,484,367,843USD | -2,887,709USD | -4,237,751USD | -2,766,697USD | -2,463,104USD | -1,806,597USD | -2,701,806USD |
| Depreciation | 36,066,000USD | 181,601,818USD | 43,654USD | 48,763USD | 50,765USD | 53,869USD | 62,637USD | 45,100USD |
| Stock Based Compensation | 630,386,000USD | 2,671,888,774USD | 620,585USD | 896,552USD | 591,089USD | 390,048USD | 883,000USD | 436,874USD |
| Other Non Cash Items | 342,975,681USD | 9,628,334,169USD | 221,108USD | 555,915USD | -1,339,342,202USD | 312,969USD | -2,073,965USD | 8,785USD |
| Change In Working Capital | 343,319USD | 469,356USD | 1,061,014USD | 1,167,303USD | 591,045USD | -21,449USD | -59,997USD | -79,633USD |
| Total Cash From Operating Activities | -1,732,597,000USD | -2,073,726USD | -941,348USD | -1,569,218USD | -1,340,876,000USD | -1,727,667USD | -2,994,922USD | -2,290,680USD |
| Capital Expenditures | 0USD | -3USD | -2USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -1,732,597,000USD | -2,073,729USD | -941,350USD | -1,569,218USD | -1,340,876,000USD | -1,727,667USD | -2,994,922USD | -2,290,680USD |
| Net Borrowings | -5,000,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | -2,100,830,000USD | 1,175,103USD | 13,545,678USD | 540USD | 576,000USD | -3USD | 6,805USD | 5,806,288USD |
| Issuance Of Capital Stock | 3,019,528USD | 1,317,443USD | 13,137,498USD | 0USD | 0USD | 0USD | 0USD | — |
| Change In Cash | -3,834,664,000USD | -920,872USD | 12,599,297USD | -1,552,984USD | -1,342,141,000USD | -1,751,199USD | -2,985,429USD | 3,496,588USD |
| Begin Period Cash Flow | 13,360,340,000USD | 14,281,212USD | 1,681,915USD | 3,234,899USD | 4,577,040,000USD | 6,328,239USD | 9,313,668USD | 5,817,080USD |
| End Period Cash Flow | 9,525,676,000USD | 13,360,340USD | 14,281,212USD | 1,681,915USD | 3,234,899,000USD | 4,577,040USD | 6,328,239USD | 9,313,668USD |
| Other Cashflows From Financing Activities | -2,098,980,938USD | -173,353USD | 13,546,217,460USD | — | 575,424USD | 5,000,000USD | 6,805USD | 6,288USD |
| Unclassified Financing Cash Flow | — | — | -13,545,809,280USD | — | — | -5,000,000USD | — | 5,800,000USD |
| Investments | — | — | — | — | — | 0USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | — | — | — | — | -3USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -12,494,260,000USD | -10,784,802USD | -22,457,859USD | -27,991,212USD | -30,212,770USD | -16,238,898USD | -23,802,182USD |
| Depreciation | 181,745,000USD | 215,437USD | 204,617USD | 121,749USD | 77,960USD | 55,060USD | 36,816USD |
| Stock Based Compensation | 2,673,997,000USD | 1,810,226USD | 3,860,366USD | 3,026,846USD | 1,744,724USD | 87,829USD | 219,571USD |
| Other Non Cash Items | 3,710,061,282USD | -1,256,065USD | -266,780USD | -2,790,809USD | 11,826,847USD | 8,083,171USD | 4,486,173USD |
| Change In Working Capital | 3,288,718USD | 459,728USD | 2,897,144USD | 8,766,583USD | 3,736,122USD | -324,932USD | 4,115,306USD |
| Total Cash From Operating Activities | -5,925,168,000USD | -9,555,476USD | -15,762,512USD | -18,866,843USD | -12,827,117USD | -8,337,770USD | -14,944,316USD |
| Capital Expenditures | 0USD | -4USD | -73,561USD | -250,046USD | -248,983USD | -95,212USD | -426,469USD |
| Free Cash Flow | -5,925,168,000USD | -9,555,476USD | -15,836,073USD | -19,116,889USD | -13,076,100USD | -8,432,982USD | -15,370,785USD |
| Net Borrowings | 0USD | 5,000,000USD | 0USD | 0USD | 9,459,346USD | 11,105,378USD | 11,436,006USD |
| Total Cash From Financing Activities | 14,721,897,000USD | 10,819,986USD | -407,173USD | -155,599USD | 49,256,873USD | 11,106,279USD | 11,436,006USD |
| Issuance Of Capital Stock | 14,454,941USD | 5,800,000USD | 0USD | 0USD | 39,797,377USD | 0USD | — |
| Change In Cash | 8,783,300,000USD | 1,209,811USD | -16,268,496USD | -19,253,103USD | 36,197,672USD | 2,392,120USD | -4,056,855USD |
| Begin Period Cash Flow | 4,577,040,000USD | 3,367,229USD | 19,635,725USD | 38,888,828USD | 2,691,156USD | 299,036USD | 4,355,891USD |
| End Period Cash Flow | 13,360,340,000USD | 4,577,040USD | 3,367,229USD | 19,635,725USD | 38,888,828USD | 2,691,156USD | 299,036USD |
| Other Cashflows From Financing Activities | 14,707,001,750USD | 19,986USD | 70,466USD | 1,595USD | 150USD | -95,212USD | 22,872,006USD |
| Investments | — | 0USD | -201,399USD | -250,046USD | -248,983USD | -95,212USD | -426,469USD |
| Sale Purchase Of Stock | — | 0USD | -477,639USD | -157,194USD | 0USD | — | — |
| Unclassified Financing Cash Flow | — | 5,800,000USD | — | — | 39,797,377USD | — | -22,872,006USD |
| Total Cashflows From Investing Activities | — | — | -73,561USD | -250,046USD | -248,983USD | -95,212USD | -426,469USD |
| Change To Liabilities | — | — | — | 6,085,690USD | -152,042USD | 413,484USD | 1,077,322USD |
| Cash And Cash Equivalents Changes | — | — | — | -19,272,488USD | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | -250,046,000USD | -248,983,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 250,296,046USD | 249,231,983USD | — | — |
| Change To Account Receivables | — | — | — | — | — | 1,801,793USD | 3,433,376USD |
| Change To Inventory | — | — | — | — | — | -1,801,793USD | -3,433,376USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.